image
Forum on Continuous Flow Chemical Process Development and Green Process New Technology Equipment Application
Green·Safe·Efficient·Sustainable
(GMT+8:00) Beijing, Chongqing, Hong Kong SAR, Urumqi
Program type
Event
Organizer
Related party
Target industry
Chemicals
Solution maturityLow - Low-medium
Program details

introduced

All relevant units: The advantages of continuous flow reaction technology are that it can improve the ability to handle thermal effects, enhance mixing capabilities and a larger operating window, allowing the development of safer, efficient, robust and sustainable synthetic production processes, and in production. The benefits are not limited to improving process safety, but also include achieving more efficient and lower-cost processes, thereby reducing downstream processing costs and labor costs. Secondly, laboratory and production-scale applications mean that continuous flow reactor technology can benefit both early R & D personnel and production engineers, promoting the development of safe, efficient and sustainable processes. In order to help various enterprises reserve technical strength and strengthen the construction of talent teams, our company will hold the "2024 Continuous Flow Chemical Process Development and Green Process New Technology Equipment Application Forum" in Shanghai City from January 18 to 20, 2024. The conference will focus on applications such as continuous flow microreactions, microseparation continuous technology, liquid-liquid extraction continuity, continuous crystallization reactors, continuous flow biological enzyme catalytic reaction technology and industrialization. All relevant units are requested to actively send personnel to participate, and relevant matters are hereby notified as follows:

Forum theme: Green·Safety·Efficiency·Sustainability

Participants:

  1. Technical leaders of relevant enterprises in petrochemical, pharmaceutical, pesticide, dye and pigment industries;

  2. Technical leaders of relevant enterprises in the fields of nanomaterial synthesis;

  3. Equipment and technology suppliers;

  4. Governments, associations, testing institutions, instrument and equipment units, research institutes and universities, etc.

programme of meetings

Meeting schedule:

January 18: Check-in at the conference hotel all day;

January 19 (morning): Opening of the conference, keynote speech, exhibition display;

January 19 (afternoon)-20 (morning): Invited presentations, exhibitions;

On January 20, the closing ceremony from 11:30 to 12:00 will end the conference!

(1) Research and development of flow chemical processes and promotion and application of continuous production technology and equipment

  1. Development and application of continuous flow technology reaction process for pharmaceuticals and fine chemicals;

  2. Research progress on mass transfer properties of microbubbles in flow chemical microreactions;

  3. Application of continuous multistage stirred reactor in catalytic hydrogenation;

  4. Continuous flow process research and development ideas and equipment selection;

  5. The difference between industrial scale-up of continuous flow process and traditional kettle process;

  6. Exothermal reaction flow chemistry and continuous flow reaction of highly exothermic reactions in CRO;

  7. Development and application of continuous catalytic oxidation technology and continuous halogenation technology;

  8. Development and application of continuous diazotization coupling technology;

  9. Development of continuous preparation process technology for downstream acrylonitrile products;

  10. Development of continuous flow synthesis process and continuous production technology for ibuprofen;

  11. Continuous manufacturing process design and development and industrial application of high-end chemicals;

  12. Development and application of continuous synthesis process technology for new propylene materials;

  13. Application of continuous flow chemistry technology in hydrogenation reduction reactions and ozone reactions;

  14. Research progress and application of continuous flow biological enzyme catalytic reaction technology;

  15. Technical application and regulatory policies for continuous manufacturing of APIs and preparations;

  16. Feasibility assessment of continuous flow reactions, process design and verification of pilot and pilot scale-up;

  17. Continuous flow technical equipment (micromixers, plate microchannels, tube bundle microchannels, fixed bed reactors, loop reactors, centrifugal extractors);

  18. Continuous flow technical auxiliary equipment (feeding system, high-pressure plunger pump, temperature control system, back pressure equipment,);

  19. Development and application of multi-module separation and purification systems for continuous flow devices;

(2) Development and application of continuous production process based on new microchannel reactors

  1. Development and industrial application of key technologies of new microchannel reactor systems;

  2. Research progress in safe and efficient synthesis processes based on microchannel reactors;

  3. Industrial application of microchannel reactors in dangerous reactions;

  4. Structural design, manufacturing and process technology development of microreactor;

  5. Application of microchannel reactors in dangerous processes for the synthesis of fine chemicals and pharmaceutical intermediates;

  6. Continuous and controllable preparation and process strengthening of micro-nano materials based on micro-reaction technology;

  7. Research, development and application of microchannel reactors in polymerization reactions;

  8. Research, development and application of microreactors in the synthesis of energetic compound materials;

  9. Design, development and application of microstructure reactor;

  10. Research and application on online monitoring and detection of slow fouling in microchannel reactors;

  11. Research and development of efficient mixing of gas-liquid-liquid three-phase reaction systems in microchannel reactors;

  12. Selection of solvent and gas carrier in process research of gas-liquid two-phase reactions;

(3) Research progress and application of green processes

  1. Development and application of a new green sulfonation process for carbochrome sodium sulfonate bulk drug;

  2. Development and application of biotechnology in chemical biomimetic and biochemistry;

  3. Green catalytic technology (phase transfer catalytic technology, enzyme catalytic technology, asymmetric catalytic technology);

  4. Organic synthesis technology in supercritical fluids;

  5. Application of membranes and new separation technologies in the chemical industry;

  6. New liquid-liquid separation continuous extraction equipment and industrial applications;

★ Display of scientific and technological innovation achievements of new equipment and new instruments:

During the conference, new equipment and new instrument achievements display activities will be held. All instruments and equipment development units are welcome to actively participate in the booth display and technology promotion report (please contact the conference group for details).

After the meeting, the inspection of Shanghai Huihe Huade Biotechnology Co., Ltd. required:

  1. Only the technical leaders of fine chemical companies such as pharmaceuticals, pesticides, and dyes and pigments and the technical leaders of relevant companies in the fields of nanomaterial synthesis can make an appointment to register (up to 2 people per unit);

  2. Due to park management factors, the number of visitors is limited to 12, and the reservation will be closed when the registration quota is full.

  3. Depart from the conference hotel for inspection at 13:00 pm on January 20, 2024.

Shanghai Huihe Huade Biotechnology Co., Ltd., a chemical "geek" who plays with microreactions, is the first company in China engaged in the development of microreactor application technology. Founded in 2015 in the China (Shanghai) Pilot Free Trade Zone, it is an innovative high-tech company focusing on continuous process development and industrialization. Huihe Huade was founded by experts in the fields of chemical synthesis and chemical industry. It was strategically invested by Dongfulong Technology (SZ300171), a leading enterprise in the field of pharmaceutical machinery. It has rich experience in continuous flow process development and industrialization. The team members all have high academic qualifications, and most of them have many years of experience in R & D and production in the pharmaceutical and fine chemical industries. The young and energetic team vows to work hard for the vision of "smart chemical industry". Huihe Huade mainly serves: fine chemical enterprises: developing continuous reaction process packages and building complete sets of functional equipment to achieve safer, more environmentally friendly and more efficient industrial production; pharmaceutical R & D enterprises: providing flow chemical development and continuous synthesis customization services.

guests of the meeting

Invited guests and report topics (in no particular order):

★ Luo Guangsheng is a professor at Tsinghua University and a Yangtze River Scholar at the Ministry of Education; director of the Joint State Key Laboratory of Chemical Engineering, founder of Tsinghua Microchemical Technology and academic leader in Separation Science and Technology. He has long been engaged in micro-scale flow chemistry, microchemical technology, separation science and technology research, multiphase flow and transfer, powder material preparation, etc. Committed to the construction of the theoretical system of microchemical industry and the breakthrough of microchemical technology from concept to industrial application, revealing the control mechanism of interfacial forces, viscous forces and other factors on multiphase microdispersion systems, developing microdispersion methods and equipment based on shear force control, analyzing microdispersion The change laws of dynamic interfacial tension during the process, researching and exploring the basic laws of micro-scale mixing, transfer and reaction and establishing mathematical models, and developing new methods to strengthen separation and reaction processes. Propose the theory and method of micro-equipment amplification and micro-chemical system integration, and invent a variety of micro-chemical equipment such as micro-trough type, micro-membrane type, multi-aperture micro-sieve type, micro-sieve array type, and micro-component combination type, breaking through a number of major problems in the industrial application of micro-chemical technology, and take the lead in realizing the industrial application of micro-chemical technology in 10,000-ton wet phosphoric acid purification, acid group extraction, nano calcium carbonate preparation, bromobutyl rubber synthesis, rubber accelerator synthesis, etc. Industrial application.

[Report Theme]: Microchemistry and Continuous Flow Synthesis Technology

★ Zhang Fuli is a researcher and doctoral supervisor. He has served successively as director and vice president of the Chemistry Department of Shanghai Pharmaceutical Industry Research Institute, director of the Pharmaceutical Process Optimization and Industrialization Engineering Research Center, and a special expert of the State Council. Adjunct professor at Fudan University, Shanghai Jiao Tong University, Shanghai University of Engineering Technology and Zhejiang University of Technology. Deputy editor-in-chief of China Journal of Modern Applied Pharmacy, and editorial board member of China Journal of Pharmaceutical Industry, Advances in Pharmacy, World Journal of Clinical Drugs, China Journal of Medicinal Chemistry and other journals. It is mainly engaged in process research on major drug varieties and development research on API and preparation varieties.

[Report Theme]: Sharing of green synthesis process development concepts and cases

★ Guo Kai, Vice President of Nanjing University of Technology, Professor and Doctoral Supervisor; Distinguished Professor of National Talents of the Ministry of Education, and Leading Talent in Scientific and Technological Innovation of National Talents of the Organization Department of the CPC Central Committee. Mainly engaged in research on microfluidic field technology and biobased materials. Hosted national and provincial scientific research projects such as national key R & D plan projects, key projects of the National Natural Science Foundation of China, and national defense science and technology innovation projects of the Central Military Commission; carried out horizontal cooperation with many companies such as China Petrochemical Company and British VT Company, and many technologies have been used in chemical, materials, pharmaceutical and other industries. Industrial transformation.

[Report Theme]: Research and development of micro-chemical technology and equipment

★ Sun Tiemin is a doctoral supervisor in pharmaceutical chemistry at Shenyang Pharmaceutical University, a second-level professor, a famous teaching teacher in Liaoning Province, the person in charge of national excellent pharmaceutical chemistry courses and shared resource courses, and the winner of the second prize for national teaching achievements. He has long been engaged in innovative drug research in the fields of anti-infection and sugar metabolism, and research on complex drug synthesis processes. He has presided over many national research projects and natural fund research, and has trained more than 100 doctoral and master's students. He is deputy editor-in-chief of the magazine "Zhongnan Pharmaceutical", is an editorial board member of many magazines such as "China Journal of Medicinal Chemistry","Journal of China Medical University", and "Journal of Shenyang Pharmaceutical University", is a reviewer of multiple SCI magazines, and has published more than 50 SCI research papers. Cooperated with enterprises on dozens of projects, with several contracts of more than 15 million yuan. It has a high reputation in the field of flow chemistry research. Published 7 research papers in top international technology research journals.

[Report Theme]: Continuous flow chemical technology-a new green and low-carbon method and development in pharmaceutical engineering

Summary: It mainly describes the application examples of flow chemistry methods in drug preparation, especially the application of static drugs among hypoglycemic drugs. Through the analysis and research of the reaction mechanism, the reaction conditions of flow chemistry are determined and better results are obtained. In semi-synthetic penicillin and cephalosporins, m-cresol is often used to hydrolyze diphenyl methanol esters. The flow chemistry method developed has obtained excellent results, making the method universal.

★ Dr. Zhang Jie, associate researcher at the Shanghai Institute for Advanced Study, China Academy of Sciences. In 2011, he graduated from the University of Lorraine, France, and then entered the Laboratory of Catalysis and Solid Chemistry at the Centrale Polytechnic University in Lille, France for postdoctoral research; in 2013, he entered the General Electric (China) Research and Development Center, mainly conducting enhanced research on carbon-based energy conversion and utilization processes. In 2018, he joined the Shanghai Institute of Advanced Studies, Chinese Academy of Sciences, and is mainly engaged in enhanced research on chemical processes based on flow chemistry and 3D printing technology. As the person in charge, he has undertaken several projects such as the National Natural Science Foundation of China, the STS Innovation and Innovation Project of the Chinese Academy of Sciences, and the Enterprise Horizontal, and has published more than 20 papers in important chemical journals such as Nano Energy, CEJ, and CES.

[Report Theme]: Green and efficient manufacturing of fine chemicals and high-end materials based on flow chemistry

Summary: Continuous flow microreactors have the advantages of large specific surface area, high mass and heat transfer efficiency, strong reaction controllability, and small amplification effect. In recent years, they have received widespread attention in the field of synthesis of fine chemicals, pharmaceutical intermediates and high-end materials. This report mainly introduces the research progress of the research group in flow chemistry in recent years, and specifically explains how to design and manufacture new microreactors based on reaction characteristics, and use CFD numerical simulation to optimize their structure. At the same time, combined with the research of macro and micro flow characteristics, the transformation of homogeneous, gas-liquid, gas-liquid-solid and other (optical/electrical) reactions from tank to continuous flow processes is realized, and the green and efficient synthesis of various fine chemicals and high-end materials is realized.

★ Dr. Chen Xiao, associate professor, doctoral supervisor, backbone of Dalian University of Technology, star of Dalian City Youth Science and Technology, and high-end talent Dalian City; graduated from Hunan University with an undergraduate degree in 2008 and obtained a doctorate in engineering from Dalian University of Technology in 2013; he has visited and exchanged at the University of Southern Carolina in the United States and Chemnitz University of Technology in Germany respectively; It is mainly engaged in research on new catalytic materials, unconventional energy conversion, fine chemical synthesis, olefin oligomerization, electrocatalytic reduction, environmental catalysis, etc.

[Report Theme]: Development of hydrogen production by electrolysis of water and continuous flow catalytic hydrogenation production technology

Summary: The creation of catalysts is the core of hydrogen energy production, green chemical manufacturing and efficient and clean utilization of resources. This report mainly introduces the chemical construction and large-scale preparation of intermetallic compounds for continuous electrolysis of water to produce hydrogen and continuous flow catalytic hydrogenation to obtain high-end fine chemicals and clean fuels, such as acetylenic alcohols, maleic anhydride, furfural, aromatic hydrocarbons, etc. Continuous flow selective hydrogenation production technology, etc.

★ Dr. Wan Li, Young Associate Researcher at the Chiral Molecular Catalysis and Synthesis Engineering Center of Fudan University; mainly engaged in the rapid and precise green manufacturing of high-performance chemicals. Based on organic reaction mechanisms and preparation process characteristics, he designs and manufactures matching microchemical devices and builds intelligence. Systematic microchemical production platform accurately controls feeding, reaction monitoring, post-processing and other links, effectively reduces production costs and waste emissions, and improves production safety. At present, as the project leader, he has undertaken 4 national and provincial and ministerial natural science funds and undertaken many corporate cooperation projects. Young expert of the Pharmaceutical and Chemical Industry Professional Committee of China Chemical Enterprise Management Association.

[Report Theme]: Development and application of flow chemical synthesis process

★ Tao Jian, deputy general manager of Tianjin Kelaying Pharmaceutical Technology Development Co., Ltd., graduated from Sichuan University with a master's degree in 2007. He joined Kelaying Pharmaceutical Group in the same year. He is currently the head of the Group's Continuous Science and Technology Center, senior engineer, and registered chemical engineer. He has more than 14 years of R & D, application and management experience in the field of continuous reaction technology, and has led and participated in the development of all continuous reaction technologies and the application and verification of continuous commercial projects of the group. He participated in the sub-project of the national "863" plan and was selected into the "131" Innovative Talent Training Project of Tianjin City, the Youth Talent Cultivation Plan of Tianjin City Binhai New Area, and the Science and Technology Progress Award of Tianjin City Binhai New District (first prize). It has authorized 91 patents and won provincial and ministerial awards such as the China Patent Excellence Award of the State Intellectual Property Office, the first prize of the Jilin Province Science and Technology Award, the first prize of the Tianjin City Binhai New District Science and Technology Progress Award. It has published many documents related to continuous reaction technology in OPRD and other journals, and won the first ACS PR GCI CMO Excellence in Green Chemistry Award as a team member.

[Report Theme]: Development of continuous reaction technology and sharing of application cases of continuous projects

★ Zhang Feng, Director of Process Chemistry of Nanjing Pharmaceutical Stone Technology, and Head of Flow Chemistry Department and Innovation Equipment Department. Successfully built the Pharmaceutical Stone Technology flow chemistry platform, and has rich experience and deep understanding in the continuous flow process development of fine chemicals and pharmaceutical intermediates and the design, processing, integration and application of flow equipment. Leading the continuous process development and production of hundreds of gram-to-tonnage-scale projects, involving reaction types of 50+, such as high temperature and high pressure (2+2, Huang Minglong's reduction, aromatic nucleophilic substitution, isomerization, etc.), cryogenic, reduction (DIBAL-H, Vitride, NaBH4, etc.), oxidation (O2, O3, H2O2, NaClO, NaClO2, etc.), diazotization, nitration, halogenation (fluorination, chlorination, bromination, iodination), azide-based reactions (azido, azide ring closure, Curtius rearrangement, etc.), photocatalytic, electrocatalysis, polymerization, etc. In addition, he has certain application experience in multi-step reaction continuity, continuous end-to-end, and PAT. Based on the continuous process development and production application of a certain product of the company, he led the team to win the 2023 CMO Green Chemistry Excellence Award awarded by the American Chemical Society (ACS) Green Chemistry Society Pharmaceutical Roundtable (GCI PR).

[Report Theme]: Application and case introduction of continuous flow process and microreaction technology in the synthesis of pharmaceutical intermediates

★ Dr. Ma Bing, Chairman of Shanghai Huihe Huade Biotechnology Co., Ltd.; He has more than 10 years of experience in the research and development and industrialization of microreaction processes. He has published more than ten papers, including JACS and Angew. He has applied for more than 40 patents. He has served as Director of Application Development and Commerce of the Reactor Technology Department of Corning in the United States. He is employee No. 1 in Greater China of Corning's Reactor Department; Ph. D. in Organic Chemistry from Brigham Young University, R & D Manager of Biotech (Beijing), with his research direction in the total synthesis of complex natural products. Bachelor's degree and master's degree in chemistry, Nanjing University. At the same time, he serves as an adjunct professor and master's supervisor at Changzhou University.

[Report Theme]: Continuous flow technology helps clean and safe production in the agrochemical industry

Summary: Since 2010, the application of continuous flow technology in the fine chemical industry has gradually become a hot spot. Foreign microreactor suppliers have deeply developed the China market, and have also driven domestic equipment manufacturers to actively follow up. Hot marketing has not promoted the industrial use of microreactor technology. There are policy reasons, technical reasons, market reasons, etc. The report will elaborate on the opportunities and challenges of microreactor technology, and at the same time illustrate the process of each project from R & D to industrialization through specific cases of Huihe Huade.

★ Chen Junwei, deputy general manager, senior engineer, and nationally registered safety engineer of Zhejiang Changhai Pharmaceutical Co., Ltd. He has been engaged in production management, engineering project construction and technological progress for a long time. During the implementation of the project, advanced continuous production and manufacturing technologies such as microchannel continuous flow reactors, membrane separation and continuous extraction separation were successfully introduced, achieving the intrinsic safety of production engineering equipment and the automated production of the system. Proficient in pharmaceutical and chemical enterprise management, engineering technology optimization application and implementation.

[Report Theme]: Develop continuous processes to create a flexible production platform

Summary: Introduce the construction background of the "Green Pharmaceutical and Safety Technology Incubation Base"(Flexible Platform) of the Ministry of Industry and Information Technology, introduction of the functions of the flexible platform, application cases of the flexible platform and other aspects, and deeply share the application of continuous manufacturing technology in industrialization. In order to meet the personalized needs of the chemical and pharmaceutical industry, achieve green and low-carbon development, further achieve intrinsic safety, respond to the "double carbon and double control" policy, enhance the comprehensive competitiveness of enterprises, and promote higher economic benefits.

★ Zhu Ruiheng, director of the pharmaceutical industry of Shanghai Hequan Pharmaceutical Research and Development Co., Ltd., graduated from East China University of Science and Technology and obtained a doctorate in pharmaceutical engineering and technology. He currently serves as director of Hequan Pharmaceutical Industry and head of the Waigaoqiao flow chemistry research and development team of the API process technology platform. Dr. Zhu has more than 8 years of professional experience in the field of flow chemistry, and has led the team to complete flow chemistry process research and development and process transfer of more than 200 pre-clinical to commercial projects. Before working in flow chemistry, he worked in the Hequan Process R & D team, mainly engaged in the development of traditional batch processes.

[Report Theme]: Sharing of new progress and application cases of flow chemistry technology in new drug research and development

Summary: Introduce the differences between flow chemistry technology and traditional batch process, introduce the development and capabilities of flow chemistry technology in Hequan Pharmaceutical in recent years, and share several cases of applying flow chemistry to develop processes and scale up production.

★ Wang Zuorong, chief engineer and senior engineer of Ningbo Xinyuan Film Industry Co., Ltd. A pioneer of internal pervaporation membranes, he has been engaged in the pervaporation membrane industry for more than ten years. He has rich experience in the research and development and application of pervaporation membranes, focusing on the dehydration of various organic solvents in the pharmaceutical, chemical, electronics and other industries.

[Report Theme]: Application Case Sharing of Pervaporation Organic Solvent Dehydration Technology

★ Kong Guichang, chairman of Hangzhou Jingjin Technology Co., Ltd., focuses on the innovative development of chemical feed pumps. He has 4 invention patents and more than 10 utility model patents. With an attitude of excellence, he is committed to the cause of precise feeding and makes good use of combined innovative thinking. Help users solve feeding problems, led the research and development of Jingrui high-pressure PTFE pump, Jingrui stainless steel/Hastelloy pump, Jingrui precision feeding system, mass flow detection controller, Jingrui explosion-proof pumps and other types are suitable for feeding systems in continuous reactions, helping users achieve stable, accurate and intelligent transportation of materials!

[Report Theme]: Technical research and application cases for achieving accurate, stable and intelligent feeding in automated, digital and continuous reactions

★ Li Yanran Product Manager of Shenzhen Yizheng Technology Co., Ltd.

[Report Theme]: Continuous Flow Overall Solutions and Case Sharing

★ Zhang Qingwu is a professor and research-level senior engineer at Beijing Rixin Yuanwang Technology Development Co., Ltd.. Since 1985, he has been engaged in biopharmaceuticals, chemical synthetic pharmaceuticals, environmental protection technology and higher education. He has made many achievements in the research and development of new drugs and the implementation of production, pharmaceutical process innovation, separation and purification, and membrane technology research and development and application. It has developed high-quality activated carbon fibers, pioneered the use of activated carbon fibers for liquid purification technology, and built related industrial chains, which has greatly promoted energy conservation, emission reduction and production cost reduction in pharmaceutical, chemical and other fields. China's pharmaceutical and fine chemical industries are a pioneer in large-scale application of pervaporation membrane/vapor permeation membrane technology in the field of organic solvent dehydration. Director of China Chemical Enterprise Management Association.

[Report Theme]: Application of high-quality activated carbon fiber membranes in flow chemical process development

★ Wang Guangzu, a researcher at the Institute of Advanced Technology, University of Science and Technology of China, and chairman of Anhui Kexin Microfluidic Chemical Technology Co., Ltd.; He is mainly engaged in the development of new photocatalytic catalytic systems and continuous flow technology research. So far, he has published 15 academic papers in internationally renowned journals "Journal of the American Chemical Society","ACS Catalysis","Science China Chemistry","Organic Letters" and "Green Chemistry", and he cited more than 600 times in SCI. Apply for 10 invention patents, authorise 6, preside over 7 vertical projects including the National Youth Fund, postdoctoral general projects, Anhui Province Youth Innovation Fund, postdoctoral scientific research grants from Anhui Province and Hefei City, and undertake 5 horizontal projects of enterprises, with a total amount of more than 5 million yuan.

[Report Theme]: Full-stack R & D and industrialization scale-up of continuous flow technology

Summary: Fine chemical industry, as one of the pillar industries of my country's national economy, has an average annual growth rate of more than 10%, and the total output value will exceed 10 trillion yuan in 2027. However, my country's fine chemical companies generally have low automation and backward production processes. The problem has caused frequent safety accidents in recent years, which has caused the public to "turn pale". Compared with the traditional batch kettle type, continuous flow technology has the advantages of high mass and heat transfer efficiency, easy direct amplification, green environmental protection and intrinsic safety. In recent years, it has received widespread attention from the scientific research community and industry. The speaker summarized the progress made by the team in continuous flow technology in recent years, especially in the field of photocatalytic continuous flow, and systematically introduced how to use continuous flow technology to provide overall solutions for chemical production.

(More expert reports are being confirmed, so stay tuned...)

Organizers and participating units

Sponsors: Pharmaceutical and Chemical Professional Committee of China Chemical Enterprise Management Association, Zhongke Kaisheng (Beijing) Chemical Technology Research Institute

Co-organizers: Shanghai Huihe Huade Biotechnology Co., Ltd., Hangzhou Jingjin Technology Co., Ltd., Shenzhen Yizheng Technology Co., Ltd., Ningbo Xinyuan Film Industry Co., Ltd., Changzhou Nayang Biotechnology Co., Ltd., Beijing Rixin Yuanwang Technology Development Co., Ltd., Mipu Technology (Changzhou) Co., Ltd.(continuing recruitment...)

Supporting units: Tsinghua University, Shanghai Pharmaceutical Industry Research Institute, Nanjing University of Technology, Shenyang Pharmaceutical University, Shanghai Institute of Advanced Studies of China Academy of Sciences, Dalian University of Technology, Chiral Molecular Catalysis and Synthesis Engineering Center of Fudan University, Zhejiang Changhai Pharmaceutical Co., Ltd., Nanjing Yaoshi Technology Co., Ltd., Tianjin Kelaiying Pharmaceutical Technology Development Co., Ltd., Shanghai Hequan Pharmaceutical Research and Development Co., Ltd.

conference fees

Conference fee: 2500 yuan/person (including meeting fees, data fees, etc.);

More than 2 people from the same enterprise register 2200 yuan/person. Colleges and universities 1800 yuan/person,

Accommodation and accommodation are arranged in a unified manner and the expenses are borne at your own expense.

Publisher
TanLIVE
Organizer
Pharmaceutical and Chemical Professional Committee of China Chemical Enterprise Management Association
Organizer
Zhongke Kaisheng (Beijing) Chemical Technology Research Institute
Related party
Shanghai Huihe Huade Biotechnology Co., Ltd.
Related party
Hangzhou Jingjin Technology Co., Ltd.
Related party
Shenzhen Yizheng Technology Co., Ltd.
Report